NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Interference of heparin with the polymerase chain reaction.

Author(s): Beutler E, Gelbart T, Kuhl W

Publication: Biotechniques, 1990, Vol. 9, Page 166

PubMed ID: 2400599 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of type of anticoagulant and refrigerated storage on the amplificability of DNA extracted from whole blood. Methods to purify DNA from residual heparin were also investigated.

Conclusion of Paper

Without additional measures taken to remove residual heparin, a fragment of the glucocerebrosidase gene could not be amplified from either fresh or refrigerated specimens collected into tubes containing sodium heparin. The glucocerebrosidase gene fragment was amplified from fresh or refrigerated specimens collected into tubes containing EDTA.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of type of anticoagulant and refrigerated storage on the amplificability of DNA extracted from whole blood. Methods to purify DNA from residual heparin were also investigated. Extraction was completed using the Applied Biosystems 340A nucleic acid extractor for unfractionated blood.

    Summary of Findings:

    Without additional measures taken to remove residual heparin, a fragment of the glucocerebrosidase gene could not be amplified from DNA extracted from either fresh or refrigerated blood specimens collected into tubes containing sodium heparin. The glucocerebrosidase gene fragment was amplified from fresh or refrigerated specimens collected into tubes containing EDTA. Separation of the leukocytes by centrifugation or sedimentation and washing the white blood cells in saline prior to DNA extraction, washing whole blood cells prior to DNA extraction, or treating the DNA with heparinase II enabled amplification of the glucocerebrosidase gene fragment from heparinized specimens. The authors state that boiling DNA along with filtration on Sephadex G-75, altering the pH followed by gel filtration, repeated ethanol precipitation, or titration with protamine sulfate did not allow amplification of the glucocerebrosidase gene fragment from heparinated specimens.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    DNA PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Anticoagulant EDTA
    Sodium heparin
    Storage Storage duration 0 d
    10 d
    Analyte Extraction and Purification Analyte purification Heparinase II treatment
    No heparinase II treatment
    Boiling DNA
    No boiling of DNA
    Acidification of DNA
    Alkalinization of DNA
    Repeated ethanol precipitation
    Titration with protamine sulfate
    Biospecimen Aliquots and Components Blood and blood products Leukocyte
    Whole blood
    Analyte Extraction and Purification Filtration of purified DNA No
    Yes
    Gel
    Sephadex
    Biospecimen Aliquots and Components Blood processing method Washed whole blood cells
    Washed white blood cells
    Unwashed blood
    PCR Specific Targeted nucleic acid Glucocerebrosidase

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...